Magnesium, vitamin D status and mortality: results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III

[1]  H. Brenner,et al.  Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies , 2013, Ageing Research Reviews.

[2]  W. Post,et al.  25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files. , 2012, Nutrition.

[3]  A. Tamakoshi,et al.  Associations of dietary magnesium intake with mortality from cardiovascular disease: the JACC study. , 2012, Atherosclerosis.

[4]  W. Grant,et al.  Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate , 2012, Dermato-endocrinology.

[5]  F. Hu,et al.  Plasma 25-Hydroxyvitamin D and Progression to Diabetes in Patients at Risk for Diabetes , 2012, Diabetes Care.

[6]  S. Larsson,et al.  Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. , 2012, The American journal of clinical nutrition.

[7]  S. Pilz,et al.  Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. , 2012, The American journal of clinical nutrition.

[8]  J. Manson,et al.  The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. , 2012, Contemporary clinical trials.

[9]  S. Tretli,et al.  Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study , 2011, Cancer Causes and Control.

[10]  E. Giovannucci,et al.  Vitamin D: epidemiology of cardiovascular risks and events. , 2011, Best practice & research. Clinical endocrinology & metabolism.

[11]  J. Manson,et al.  Vitamin D intake and risk of cardiovascular disease in US men and women. , 2011, The American journal of clinical nutrition.

[12]  J. Mitri,et al.  Vitamin D and type 2 diabetes: a systematic review , 2011, European Journal of Clinical Nutrition.

[13]  J. Manson,et al.  Vitamin D and prevention of cardiovascular disease and diabetes: why the evidence falls short. , 2011, JAMA.

[14]  J. Manson,et al.  Vitamin D and prevention of cancer--ready for prime time? , 2011, The New England journal of medicine.

[15]  M. Stampfer,et al.  Circulating Levels of Vitamin D and Colon and Rectal Cancer: The Physicians' Health Study and a Meta-analysis of Prospective Studies , 2011, Cancer Prevention Research.

[16]  R. Heaney,et al.  Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. , 2011, Anticancer research.

[17]  Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines. , 2011, Dermato-endocrinology.

[18]  Christine L. Taylor,et al.  Committee to Review Dietary Reference Intakes for Vitamin D and Calcium , 2011 .

[19]  E. Taylor,et al.  Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey , 2011, Osteoporosis International.

[20]  細田 徹,et al.  海外情報 Brigham and Women's Hospital, Harvard Medical School , 2010 .

[21]  C. Abnet,et al.  Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). , 2010, Cancer research.

[22]  Daniel L. Koller,et al.  Common genetic determinants of vitamin D insufficiency: a genome-wide association study , 2010, The Lancet.

[23]  R. Berg,et al.  A Systematic Review and Meta-analysis , 2010 .

[24]  B. Kupelnick,et al.  Colorectal Cancer Risk and Dietary Intake of Calcium, Vitamin D, and Dairy Products: A Meta-Analysis of 26,335 Cases From 60 Observational Studies , 2008, Nutrition and cancer.

[25]  J. Eisman,et al.  Global vitamin D status and determinants of hypovitaminosis D , 2009, Osteoporosis International.

[26]  B. Astor,et al.  25-hydroxyvitamin D levels and the risk of mortality in the general population. , 2008, Archives of internal medicine.

[27]  E. Giovannucci.  Epidemiological Evidence for Vitamin D and Colorectal Cancer , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  W. Zheng,et al.  The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk. , 2007, The American journal of clinical nutrition.

[29]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[30]  M. Holick.  Resurrection of vitamin D deficiency and rickets. , 2006, The Journal of clinical investigation.

[31]  D. Hosking,et al.  Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency , 2006, Osteoporosis International.

[32]  J. Manson,et al.  Dietary magnesium intake and risk of cardiovascular disease among women. , 2005, The American journal of cardiology.

[33]  N. Kagawa,et al.  Metabolism of vitamin D3 by cytochromes P450. , 2005, Frontiers in bioscience : a journal and virtual library.

[34]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.

[35]  P. Trumbo,et al.  Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. , 1998, Journal of the American Dietetic Association.

[36]  its Panel on Folate,et al.  STANDING COMMITTEE ON THE SCIENTIFIC EVALUATION OF DIETARY REFERENCE INTAKES , 1998 .

[37]  M. Traba,et al.  Possible involvement of a magnesium dependent mitochondrial alkaline phosphatase in the regulation of the 25-hydroxyvitamin D3-1 alpha-and 25-hydroxyvitamin D3-24R-hydroxylases in LLC-PK1 cells. , 1994, Magnesium research.

[38]  Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. , 1994, Vital and health statistics. Ser. 1, Programs and collection procedures.

[39]  B. Hollis,et al.  Human plasma transport of vitamin D after its endogenous synthesis. , 1993, The Journal of clinical investigation.

[40]  M. Traba,et al.  Influence of magnesium on the in vitro synthesis of 24,25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3. , 1992, Magnesium research.

[41]  P. Bergmann,et al.  CORRECTION OF LOW CIRCULATING LEVELS OF 1,25‐DIHYDROXYVITAMIN D BY 25‐HYDROXYVITAMIN D DURING REVERSAL OF HYPOMAGNESAEMIA , 1989, Clinical endocrinology.

[42]  J. Adams,et al.  Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency. , 1985, The Journal of clinical endocrinology and metabolism.

[43]  W. Priester,et al.  Letter: Green-tobacco sickness. , 1975, Lancet.

[44]  V. Reddy,et al.  Magnesium-dependent vitamin-D-resistant rickets. , 1974, Lancet.

[45]  A. Rösler,et al.  Magnesium-induced reversal of vitamin-D resistance in hypoparathyroidism. , 1973, Lancet.

[46]  H. DeLuca,et al.  In vitro production of 25-hydroxycholecalciferol. , 1969, Biochemical and biophysical research communications.